Which hedge funds own AMRX? AMNEAL PHARMACEUTICALS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in AMRX (AMNEAL PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $212.0m in total. The largest holder by portfolio weight is Rubric Capital Management at 1.6% of its book. 1 exited: Point72 Asset Management LP.
6tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold AMRX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Rubric Capital Management | Q2 2026 | 1.6% | $176.0m | 10,168,660 | -8% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $1.5m | 85,545 | -41% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $19.4m | 1,118,715 | 94% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $13.4m | 774,055 | -55% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $1.5m | 87,487 | -68% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $255.5k | 14,761 | -96% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Point72 Asset Management LP | 0.0% | $970.8k |
How has hedge fund ownership of AMRX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $212.0m |
| Q1 2026 | 7 | $176.5m |
| Q4 2025 | 3 | $156.3m |
| Q3 2025 | 3 | $125.3m |
| Q2 2025 | 2 | $98.2m |
| Q1 2025 | 5 | $112.8m |
| Q4 2024 | 3 | $94.8m |
| Q3 2024 | 4 | $109.1m |
| Q2 2024 | 3 | $80.8m |
| Q1 2024 | 5 | $66.1m |
| Q4 2023 | 3 | $50.3m |
| Q3 2023 | 4 | $18.5m |
| Q2 2023 | 1 | $8.1m |
| Q4 2022 | 1 | $152.0k |
| Q3 2022 | 2 | $5.8m |
| Q2 2022 | 2 | $11.6m |
Counts every tracked manager that disclosed AMRX in that quarter's filing, including managers that have since stopped filing.